These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1689508)

  • 1. Biologic response modifiers in non-Hodgkin's lymphomas.
    Gilewski TA; Richards JM
    Semin Oncol; 1990 Feb; 17(1):74-87. PubMed ID: 1689508
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
    Hendrix C
    ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-Hodgkin's lymphomas.
    Bartlett NL; Wagner ND
    Cancer Chemother Biol Response Modif; 1999; 18():293-323. PubMed ID: 10800489
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of adult non-Hodgkin's lymphomas.
    Gobbi PG; Cavalli C
    Haematologica; 1986; 71(4):321-43. PubMed ID: 2430865
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
    Skarin AT
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.
    LaCasce AS; Freedman AS
    Semin Hematol; 2008 Apr; 45(2):85-9. PubMed ID: 18381102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
    Wörmann B; Unterhalt M; Hiddemann W
    Internist (Berl); 1993 Feb; 34(2):132-8. PubMed ID: 8454426
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic therapies for low-grade lymphomas.
    Parkinson DR; Sznol M; Cheson BD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):111-7. PubMed ID: 8211201
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological response modifiers in melanoma.
    Bridgewater JA; Gore ME
    Br Med Bull; 1995 Jul; 51(3):656-77. PubMed ID: 7552087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bio-therapy in hematology: New treatment of non-hodgkin's lymphomas with monoclonal antibodies].
    Rupniewska ZM; Legieć W
    Pol Arch Med Wewn; 1994 Aug; 92(2):193-5. PubMed ID: 7800589
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the low-grade non-Hodgkin's lymphomas.
    Portlock CS
    Semin Oncol; 1990 Feb; 17(1):51-9. PubMed ID: 2406918
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomodulators in cancer treatment.
    Mitchell MS
    J Clin Pharmacol; 1992 Jan; 32(1):2-9. PubMed ID: 1371295
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-2 therapy with or without lymphokine-activated killer-cell infusions for low-grade non-Hodgkin's lymphomas?
    Levy R; Tourani JM; Andrieu JM
    J Clin Oncol; 1992 Aug; 10(8):1366. PubMed ID: 1634929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas].
    Sack A; Meusers P
    Strahlenther Onkol; 1999 Apr; 175(4):192-3. PubMed ID: 10230466
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and programmed cell death.
    Winter JN
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):26-33. PubMed ID: 10561015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
    Gola A
    Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A revolution in the treatment of non-Hodgkin's lymphoma.
    DeNardo GL; O'Donnell RT; Oldham RK; DeNardo SJ
    Cancer Biother Radiopharm; 1998 Aug; 13(4):213-23. PubMed ID: 10850358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma.
    Fisher RI
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):2-8. PubMed ID: 11225996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody therapies for follicular non-Hodgkin's lymphomas: moving toward a cure.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):39-40. PubMed ID: 17824558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.